Fabrication of a Novel MIL-88A@ZnCoFe LDH Composite for the Sensitive Detection of Anticancer Drug Regorafenib in Biological and Pharmaceutical Samples


ERK N., Özata Ç. A., Bouali W., Genc A. A., Ahmed H. E. H., SALAMAT Q., ...Daha Fazla

Industrial and Engineering Chemistry Research, cilt.64, sa.12, ss.6240-6251, 2025 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 64 Sayı: 12
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1021/acs.iecr.4c04590
  • Dergi Adı: Industrial and Engineering Chemistry Research
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Applied Science & Technology Source, Aqualine, Chemical Abstracts Core, Chimica, Compendex, Computer & Applied Sciences, zbMATH, DIALNET
  • Sayfa Sayıları: ss.6240-6251
  • Erciyes Üniversitesi Adresli: Evet

Özet

Regorafenib (RGR) is a highly selective diphenylurea multikinase inhibitor and anticancer agent that provides survival after standard therapies for metastatic colorectal cancer. To accurately and sensitively detect RGR, a novel MIL-88A, and ZnCoFe LDH composite was successfully synthesized and modified onto a glassy carbon electrode (MIL-88A@ZnCoFe LDH/GCE). The prepared electrode significantly improved the electron transfer between the electrode and the analyte, resulting in a more sensitive response to RGR oxidation under optimal conditions. Using differential pulse voltammetry (DPV), the developed electrochemical sensor exhibited a wide linear range from 0.01 to 16.4 μM, a low detection limit (LOD = 2.241 nM), and high selectivity in the presence of various interferences. The MIL-88A@ZnCoFe LDH/GCE was successfully applied for the detection of RGR in various samples, including human urine, human serum, and tablet dosage forms, achieving satisfactory recoveries ranging from 100.14 to 103.85%, thereby demonstrating its applicability in real-world applications.